Latest Articles
-
How Abbott Could Gain From Cutting Formula Prices In China
Abbott Labs (NYSE:ABT) is cutting the prices of its baby formula products in China by 4%-12%. The move comes after the Chinese regulators started an anti-trust investigation against the company and a handful of its peers such as Mead Johnson, Nes...
-
A Look At Abbott’s Nutritional Business
Abbott Labs (NYSE:ABT) is a diversified healthcare conglomerate with a global presence. The company spun off its proprietary pharmaceutical business as Abbvie (NYSE:ABBV) earlier this year and now operates in four main segments: Nutritionals, Dia...
-
Emerging Markets Drive Abbott Laboratories’ Growth And $38 Fair Value
Established in 1888, Abbott Labs (NYSE:ABT) is a diversified healthcare conglomerate with a global presence. The company spun off its proprietary pharmaceutical business as Abbvie (NYSE:ABBV) earlier this year and now operates in four main segmen...
-
Wednesday’s Small Cap Biotech Catalyst Watch And Trade List
Submitted by Scott Matusow as part of our contributors program . Below, I have listed 5 biotechs with near-term fundamental catalysts that should see their respective prices on the move. I also list the chart for each company and offer my pric...
-
Near Term Catalysts And High Insider Ownership Makes GTx An Attractive Buy
Submitted by Scott Matusow as part of our contributors program . Today, we are going to take a comprehensive look at a small cap biotech company with several near term catalysts, a strong cash position, and high insider ownership. I feel with ...
-
Biotech Micro Caps Offer Promise of Mighty Returns: Dick Huebner
Submitted by The Life Sciences Report as part of our contributors program . This interview was conducted by George S. Mack of The Life Sciences Report (4/25/13) Dick Huebner knows what he wants. He’s looking for biotech companies that ...
-
Nutritionals Growth Abroad Fuels Abbott’s Results
Abbott Laboratories (NYSE:ABT) announced on April 17th that its total sales for the first quarter of 2013 were almost $5.4 billion, up 1.8% from the same period last year. As mentioned in our pre-earnings analysis, the primary driver for this gr...
-
Abbott Labs Pre-Earnings: Nutritionals To Drive Growth
Abbott Labs (NYSE:ABT) is scheduled to release its earnings for the first quarter of this year on April 17. This is the first earnings result after the company spun off its proprietary pharmaceutical division as Abbvie Inc (NYSE:ABBV) and all ey...
-
20 Best Yielding Healthcare Stocks Less Volatile Than The Market
Submitted by Dividend Yield as part of our contributors program . This month I like to show you the best yielding large cap stocks from all sectors that are less volatile than the market. I will start today with the healthcare sector. It̵...
-
Cheapest Dividend Paying Large Caps As of March 2013
Submitted by Dividend Yield as part of our contributors program . Some investors say that growth matters and price ratios too. They are right. If you buy a stocks with a low valuation compared to the intrinsic value, you can make a solid retur...
-
Weekly Healthcare Note: Abbott Labs And Intuitive Surgical
The past week has been eventful for the healthcare sector. During the week, Abbott Labs (NYSE: ABT) got conflicting responses relating to the pending approval of MitraClip. While the FDA staff recommended against approving the device seeking more...
-
Weekly Healthcare Note: Boston Scientific And Abbott Labs
The past week has been eventful for the healthcare sector, impacting two medical device companies under our coverage. During the week, Boston Scientific (NYSE:BSX) released data from a clinical trial called “Prevail”, where its Watchm...
-
Weekly Healthcare Notes: Abbott Labs, Merck, Pfizer & JNJ
The past week has been eventful for the healthcare sector, impacting many healthcare companies under our coverage. Firstly, the news of first ever case of a child being functionally cured of HIV infection surfaced and Abbott Labs ‘ (NYSE:AB...
-
10 Best Dividend Paying Drug Manufacturing Stocks
Submitted by Dividend Yield as part of our contributors program . The best dividend paying stocks from the major drug manufacturing industry originally published at “ long-term-investments.blogspot.com “. The healthcare sector is a...
-
Senesco Technologies Advances Genetic Cancer Treatment
Submitted by Jade Morgan as part of our contributors program . Cancer plagues the human race like no other disease, killing roughly 1,500 Americans each day and 7.6 million people worldwide each year. Companies around the world aggressively cond...
